Why Pharmaceutical's Research Model Should Replace Design Thinking

Key Insights

• •

  Business leaders value design more for elimination of redundant processes and features than for creating new innovations.

• •

  Integrated discovery research is a faster, smaller-scale approach that de-risks innovation by saving money and guiding investment decisions early.

• •

  Large discovery efforts should be reserved for genuinely new markets or disruptive initiatives and need strong executive champions.

• •

  Pharmaceutical research principles emphasize failing poor ideas quickly and cheaply to save time and money, a model applicable to UX and product development.

• •

  Most teams do not practice true dual-track agile, and adopting integrated discovery can support more agile, iterative innovation.

• •

  Positioning research as de-risking financial investments, rather than solely as customer empathy or idea generation, increases its strategic business value.

• •

  To innovate successfully amid expensive capital and economic uncertainty, UX must closely collaborate with finance teams to project ROI and viability.

• •

  Testing concept stability and market fit early helps avoid costly investments in ideas unlikely to meet customer demand or price acceptance.

• •

  Inclusive innovation benefits by expanding ideation across diverse team members rather than only from traditional leaders or designers.

• •

  Researchers must be willing to fail ideas quickly, even those championed by colleagues, to protect organizational resources and improve decision-making.

Notable Quotes